RACHEL HETZNER: Open Payments
NPI 1154729960 · MADISON HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 63 payments from 16 companies in 2025. Trend: 2023 $1,490 · 2024 $1,635 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $221 |
| AstraZeneca Pharmaceuticals LP | 9 | $166 |
| PFIZER INC. | 8 | $154 |
| Alexion Pharmaceuticals, Inc. | 1 | $116 |
| Astellas Pharma US Inc | 4 | $97 |
| ABBVIE INC. | 3 | $76 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Abbott Laboratories | 3 | $67 |
| Amgen Inc. | 3 | $56 |
Products named: CAPLYTA, Ozempic, PREVNAR 20, Veozah, FARXIGA, VRAYLAR, FREESTYLE LIBRE 3, Wegovy.
Industry payments across MI — which companies pay providers there.
